Early Detection of Liver Cancer: Essential Diagnostic Methods

Among the various diagnostic tools available, alpha-fetoprotein (AFP) testing, computed tomography (CT), and magnetic resonance imaging (MRI) are considered the most valuable for detecting liver cancer. In clinical settings, a rapid increase in AFP levels combined with the discovery of a new space-occupying lesion in the liver through CT or MRI scans strongly indicates hepatocellular carcinoma (HCC), the most common type of liver cancer.

For individuals at high risk—such as those over the age of 40 with a long-term hepatitis B virus (HBV) infection—regular AFP testing is a crucial screening method. It plays a key role in identifying early-stage liver cancer when treatment is most effective. If AFP levels are elevated, further imaging tests should be conducted to examine the liver for any new abnormal growths.

Timely surgical intervention is one of the most effective treatments for liver cancer. When detected early, surgical removal of the tumor can significantly improve prognosis, potentially extending survival for five to ten years or more. This early treatment approach greatly enhances the chances of a favorable outcome.

In summary, combining blood tests like AFP with advanced imaging techniques such as CT and MRI is essential for accurate and early liver cancer diagnosis. These methods together provide a comprehensive assessment that supports prompt and effective treatment planning.